Salvage Radioligand Therapy with Repeated Cycles of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement

Salvage Radioligand Therapy with Repeated Cycles of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement

Advanced stage metastatic prostate cancer with extensive bone marrow involvement is associated with a high risk of therapy-induced myelotoxicity and unfavorable outcomes. The role of salvage radioligand therapy (RLT) with <sup>177</sup>Lu-PSMA-617 in this subset of patients remains to be...

Full description

Bibliographic Details
Main Authors: Daniel Groener, Justus Baumgarten, Sebastian Haefele, Christian Happel, Konrad Klimek, Nicolai Mader, Christina Nguyen Ngoc, Nikolaos Tselis, Felix K. H. Chun, Frank Grünwald, Amir Sabet
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
PSMA
<sup>177</sup>Lu-PSMA-617
diffuse marrow involvement
metastatic castration-resistant prostate cancer
Online Access:https://www.mdpi.com/2072-6694/13/16/4017

Internet

https://www.mdpi.com/2072-6694/13/16/4017

Similar Items